You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV Preventive Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Participants in Preventive HIV Vaccine Studies in Uganda

Completed
  • HIV Infections
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV Trial in Worldwide (rAd5 Gag-Pol Env A/B/C, rAd5 Gag-Pol)

    Completed
    • HIV Infections
    • rAd5 Gag-Pol Env A/B/C
    • rAd5 Gag-Pol
    • Boston, Massachusetts
    • +6 more
    Oct 13, 2021

    HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)

    Completed
    • HIV Infections
    • DNA Vaccine
    • +5 more
    • Birmingham, Alabama
    • +9 more
    Oct 13, 2021

    Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)

    Active, not recruiting
    • Pneumococcal Disease
    • V116
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Dec 21, 2022

    Hiv Trial in Mumbai (CHALO! 2.0, Attention-matched control (AMC), Digital coupon only (DCO))

    Recruiting
    • Hiv
    • CHALO! 2.0
    • +2 more
    • Mumbai, Maharashtra, India
      The Humsafar Trust
    Jan 31, 2023

    Healthy Trial (763SIP8/MPLA-5 vaccine)

    Not yet recruiting
    • Healthy
    • 763SIP8/MPLA-5 vaccine
    • (no location specified)
    Mar 15, 2023

    Learn About The Effects Of Pneumococcal Vaccine In People With

    Not yet recruiting
    • HIV
    • +2 more
    • Vaccine Administration
    • New York, New York
      Pfizer
    Mar 20, 2023

    HIV Trial in South Africa (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Placebo)

    Completed
    • HIV Infections
    • ALVAC-HIV (vCP2438)
    • +2 more
    • Mthatha, Eastern Cape, South Africa
    • +13 more
    May 17, 2022

    HIV Trial in Worldwide (PENNVAX-G DNA Vaccine, MVA-CMDR Vaccine, Placebo PENNVAX-G Vaccine)

    Completed
    • HIV Infections
    • PENNVAX-G DNA Vaccine
    • +3 more
    • Rockville, Maryland
    • +3 more
    Oct 28, 2021

    HIV, Pregnancy, HIV Seronegativity Trial (MF59, rgp120/HIV-1 SF-2)

    Withdrawn
    • HIV Infections
    • +2 more
    • MF59
    • rgp120/HIV-1 SF-2
    • (no location specified)
    Oct 28, 2021

    Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)

    Not yet recruiting
    • Vaccination; Infection
    • Vaccine Adverse Reaction
    • Recombinant zoster vaccination
    • (no location specified)
    Jun 9, 2023

    HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )

    Withdrawn
    • HIV Infections
    • VRC-HIVDNA016-00-VP
    • +3 more
    • (no location specified)
    Oct 28, 2021

    HIV Trial in Birmingham, San Francisco, Seattle (pGA2/JS2 Plasmid DNA Vaccine)

    Completed
    • HIV Infections
    • pGA2/JS2 Plasmid DNA Vaccine
    • Birmingham, Alabama
    • +3 more
    Oct 13, 2021

    HIV Trial in Pittsburgh (rgp120/HIV-1 SF-2, Env 2-3, HIVAC-1e)

    Completed
    • HIV Infections
    • rgp120/HIV-1 SF-2
    • +3 more
    • Pittsburgh, Pennsylvania
      JHU AVEG
    Oct 27, 2021

    HIV Trial in United States (MRKAd5 HIV-1 gag/pol/nef)

    Completed
    • HIV Infections
    • MRKAd5 HIV-1 gag/pol/nef
    • Birmingham, Alabama
    • +3 more
    Oct 13, 2021

    Tuberculosis, HIV Coinfection, Tuberculosis Infection Trial (patient-centered TB preventive therapy, TB preventive therapy

    Not yet recruiting
    • Tuberculosis
    • +2 more
    • patient-centered TB preventive therapy
    • TB preventive therapy adherence support
    • (no location specified)
    Apr 21, 2022

    HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)

    Completed
    • HIV Infections
    • HIV Seronegativity
    • Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
    • +3 more
    • Baltimore, Maryland
      JHU AVEG
    Oct 27, 2021

    Tuberculosis, HIV/AIDS Trial in Kampala (SPIRIT Intervention)

    Active, not recruiting
    • Tuberculosis
    • HIV/AIDS
    • SPIRIT Intervention
    • Kampala, Uganda
      Infectious Diseases Research Collaboration
    Oct 14, 2022

    HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))

    Completed
    • HIV Infections
    • HIV Seronegativity
    • ALVAC(2)120(B,MN)GNP (vCP1452)
    • Birmingham, Alabama
    • +12 more
    Oct 13, 2021

    HIV Trial in Entebbe, Kampala (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65))

    Completed
    • HIV Infections
    • ALVAC-HIV MN120TMG (vCP205)
    • ALVAC-RG Rabies Glycoprotein (vCP65)
    • Entebbe, Uganda
    • +1 more
    Oct 28, 2021

    HIV Trial in United States (VRC-HIVADV014-00-VP)

    Completed
    • HIV Infections
    • VRC-HIVADV014-00-VP
    • Baltimore, Maryland
    • +7 more
    Oct 13, 2021

    HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

    Completed
    • HIV Infections
    • gp160 Vaccine (Immuno-AG)
    • +4 more
    • Rochester, New York
    • +1 more
    Oct 28, 2021

    HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

    Not yet recruiting
    • HIV Vaccine
    • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
    • +2 more
    • São Paulo, Brazil
      Hospital das Clínicas da Faculdade de Medicina da USP
    Mar 14, 2023

    HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))

    Completed
    • HIV Infections
    • HIV Seronegativity
    • ALVAC-HIV MN120TMG (vCP205)
    • Birmingham, Alabama
    • +5 more
    Oct 28, 2021

    HIV Trial in Boston, Seattle (HIV-1 DNA plasmid vaccine, HIV-1 recombinant Ad5 vaccine)

    Completed
    • HIV Infections
    • HIV-1 DNA plasmid vaccine
    • HIV-1 recombinant Ad5 vaccine
    • Boston, Massachusetts
    • +1 more
    Oct 13, 2021